This post was originally published on this site.
The Wall Street Journal editorial board is not happy with President Donald Trump’s latest plan to try to squeeze down the price of prescription drugs — an issue that has become popular in both parties in recent years, but that businesses are leery of.Indeed, argued the board, Trump’s new policy repr…